2007
DOI: 10.1016/j.annemergmed.2006.11.010
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective Evaluation of Shortened Course Oral N-Acetylcysteine for the Treatment of Acute Acetaminophen Poisoning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(35 citation statements)
references
References 17 publications
0
34
0
1
Order By: Relevance
“…The average time from earliest laboratory evidence of clearance to hospital discharge was 35 h. This calculation was performed in an attempt to measure the potential impact of routine use of patient-tailored NAC treatment protocols. [5,6,10] The maximum potential impact in this cohort was 157 hospital admission days per year (Total earliest laboratory clearance to DC hours/24 h/3.5 years). While it is clear that patients could never be discharged immediately upon laboratory clearance, this represents an area where meaningful efficiency improvements could be made in the management of APAP overdose patients.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The average time from earliest laboratory evidence of clearance to hospital discharge was 35 h. This calculation was performed in an attempt to measure the potential impact of routine use of patient-tailored NAC treatment protocols. [5,6,10] The maximum potential impact in this cohort was 157 hospital admission days per year (Total earliest laboratory clearance to DC hours/24 h/3.5 years). While it is clear that patients could never be discharged immediately upon laboratory clearance, this represents an area where meaningful efficiency improvements could be made in the management of APAP overdose patients.…”
Section: Discussionmentioning
confidence: 99%
“…In order to estimate potential times to completion of NAC therapy using patient-tailored protocols [5,6,10], a theoretical model for predicting when patients might have been cleared from antidotal therapy was developed. The "earliest laboratory evidence of clearance time" was defined as the time when available labs demonstrated that the APAP level was undetectable (less than 10 μg/mL) and the patient's liver transaminases were normal (AST<60 IU/L, ALT<60 IU/L).…”
Section: Data Collectionmentioning
confidence: 99%
See 2 more Smart Citations
“…The FDA approved a 72-h oral NAC regimen in 1985. However, evidence supports using shorter oral NAC courses provided that liver enzymes and synthetic function are normal or improving, and plasma APAP concentration is undetectable [1,2]. I n t r a v e n o u s N A C ( A c e t a d o t e ® , C u m b e r l a n d Pharmaceuticals) was approved by the FDA in 2004 and is indicated to prevent or lessen hepatic injury after potentially toxic APAP ingestion.…”
Section: Disclaimermentioning
confidence: 99%